Drugs / ASA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT03683628 Comparator | Oct 2018 → Dec 2023 | atherosclerotic cardiovascular disease, intermittent vascular claudication, peripheral arterial disease | Mahidol University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASA | “Patients will receive ASA 81 mg once daily and walking exercise 3 times/ week” NCT03683628 ↗ |